Resolution of steatohepatitis and no worsening ofliver fibrosis.Improvement of liver fibrosis and no worseningof steatohepatitis.Decrease in MASLD activity score.Reduction in liver fat content and reduction in ALT. The gene discussed is GPT; the disease is Hepatic fibrosis.